A detailed history of Brown Advisory Inc transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Brown Advisory Inc holds 16,962 shares of ANIP stock, worth $955,978. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,962
Previous 16,962 -0.0%
Holding current value
$955,978
Previous $1.08 Million 6.39%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$58.53 - $68.82 $87,209 - $102,541
-1,490 Reduced 8.08%
16,962 $1.08 Million
Q3 2023

Oct 24, 2023

SELL
$50.28 - $64.61 $80,448 - $103,376
-1,600 Reduced 7.98%
18,452 $1.07 Million
Q2 2023

Jul 31, 2023

SELL
$37.29 - $53.83 $63,393 - $91,511
-1,700 Reduced 7.82%
20,052 $1.08 Million
Q2 2022

Nov 14, 2022

BUY
$23.09 - $33.46 $95,084 - $137,788
4,118 Added 23.35%
21,752 $645,000
Q2 2022

Aug 02, 2022

BUY
$23.09 - $33.46 $95,084 - $137,788
4,118 Added 23.35%
21,752 $645,000
Q1 2022

Nov 14, 2022

SELL
$26.91 - $47.15 $110,815 - $194,163
-4,118 Reduced 18.93%
17,634 $496,000
Q1 2022

May 09, 2022

BUY
$26.91 - $47.15 $89,691 - $157,150
3,333 Added 23.31%
17,634 $496,000
Q1 2021

May 14, 2021

SELL
$28.4 - $36.14 $5,112 - $6,505
-180 Reduced 1.24%
14,301 $517,000
Q4 2020

Feb 12, 2021

BUY
$23.69 - $31.47 $4,264 - $5,664
180 Added 1.26%
14,481 $420,000
Q3 2020

Nov 16, 2020

BUY
$26.38 - $33.1 $52,522 - $65,902
1,991 Added 16.17%
14,301 $403,000
Q3 2019

Nov 14, 2019

BUY
$64.7 - $85.39 $77,640 - $102,468
1,200 Added 10.8%
12,310 $897,000
Q1 2019

May 15, 2019

BUY
$45.83 - $70.54 $509,171 - $783,699
11,110 New
11,110 $784,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $982M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Brown Advisory Inc Portfolio

Follow Brown Advisory Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brown Advisory Inc with notifications on news.